{"product_id":"peptide-therapy-profitability","title":"How Increase Peptide Therapy Clinic Profits?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003ePeptide Therapy Clinic Strategies to Increase Profitability\u003c\/h2\u003e\n\u003cp\u003eYour Peptide Therapy Clinic starts with a strong margin profile, targeting an initial EBITDA margin of around 340% in 2026 The goal is to scale this toward 55% or higher within three years by optimizing staff utilization and reducing supply chain costs Initial annualized revenue is projected near $147 million, but the high fixed costs-including $20,000 monthly for facility and operations, plus administrative wages-demand high patient volume\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Strategies to Increase Profitability of \u003c\/span\u003ePeptide Therapy Clinic\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eStrategy\u003c\/th\u003e\n\u003cth\u003eProfit Lever\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eExpected Impact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eMaximize Staff Utilization\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eFill the 45% RN capacity gap and 55% Health Coach gap starting in 2026.\u003c\/td\u003e\n\u003ctd\u003eDrives high contribution margin since fixed costs are already covered.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eImplement Tiered Pricing\u003c\/td\u003e\n\u003ctd\u003ePricing\u003c\/td\u003e\n\u003ctd\u003eRaise MD treatment prices from $850 in 2026 to $950 by 2030 and introduce premium packages.\u003c\/td\u003e\n\u003ctd\u003eAchieves 3-5% annual price increase across key services.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eOptimize Service Mix\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eShift patient volume toward NP treatments ($450 ATV) over lower-margin RN services ($250 ATV).\u003c\/td\u003e\n\u003ctd\u003eDirectly increases the overall Average Transaction Value (ATV).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eNegotiate Peptide Sourcing\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eConsolidate vendors to force a 10-15% cost reduction on Sourcing (85% of revenue) and Lab Fees (45% of revenue).\u003c\/td\u003e\n\u003ctd\u003eSignificantly lowers variable costs tied to service delivery.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eRight-Size Clinical Labor\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eMake sure high-cost MDs focus only on complex cases, delegating routine tasks to RNs or Phlebotomists.\u003c\/td\u003e\n\u003ctd\u003eImproves utilization rate for $850 per treatment staff time.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eLower Customer Acquisition Cost (CAC)\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eReduce Digital Marketing spend from 60% of revenue down to 40% by Year 4 by prioritizing retention.\u003c\/td\u003e\n\u003ctd\u003eCuts the high initial cash burn associated with new patient acquisition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eReview Overhead Leases\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eScrutinize the $12,500\/month Premium Clinic Lease and other non-wage fixed overhead upon renewal dates.\u003c\/td\u003e\n\u003ctd\u003eReduces the $20,000 monthly fixed overhead burden.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is our true contribution margin (CM) per treatment type right now?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eDetermining your true contribution margin (CM) requires subtracting all variable costs-peptides, lab fees, supplies, and acquisition costs-from the service price for MD, NP, and RN offerings to pinpoint which mix drives the highest dollar contribution, a key step detailed in \u003ca href=\"\/blogs\/write-business-plan\/peptide-therapy\"\u003eHow To Write A Business Plan For Peptide Therapy Clinic?\u003c\/a\u003e If the average MD service price is \u003cstrong\u003e$1,200\u003c\/strong\u003e with variable costs totaling \u003cstrong\u003e$500\u003c\/strong\u003e, the CM is \u003cstrong\u003e$700\u003c\/strong\u003e; you need to map this against the volume you can actually handle. Honestly, focusing only on the highest percentage margin service can hide lower absolute dollar returns.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVariable Cost Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIsolate the cost of the specific peptide compound per dose.\u003c\/li\u003e\n\u003cli\u003eTrack lab fees associated with biomarker testing.\u003c\/li\u003e\n\u003cli\u003eCalculate the cost of supplies, like syringes and vials.\u003c\/li\u003e\n\u003cli\u003eAllocate patient acquisition costs (CAC) to each service type.\u003c\/li\u003e\n\u003cli\u003eDefine what portion of practitioner time is truly variable.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eContribution Drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMD service yields the highest dollar CM, say \u003cstrong\u003e$700 per treatment\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eNP service might offer a better percentage margin, maybe \u003cstrong\u003e56%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFocus volume on the service with the highest absolute dollar contribution.\u003c\/li\u003e\n\u003cli\u003eIf RN treatments are only \u003cstrong\u003e$200 CM\u003c\/strong\u003e, ensure they fill scheduling gaps, not primary slots.\u003c\/li\u003e\n\u003cli\u003eWe need to defintely track the mix shift month-over-month.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow quickly can we push clinical staff utilization rates above 70%?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eReaching 70% utilization for your Peptide Therapy Clinic staff requires immediate, targeted patient acquisition growth, as current 2026 projections sit significantly lower at \u003cstrong\u003e55% for MDs\u003c\/strong\u003e and \u003cstrong\u003e45% for RNs\u003c\/strong\u003e, a scenario we explore defintely when looking at \u003ca href=\"\/blogs\/operating-costs\/peptide-therapy\"\u003eWhat Are Peptide Therapy Clinic Operating Costs?\u003c\/a\u003e. We must tightly link marketing spend, currently \u003cstrong\u003e60% of revenue\u003c\/strong\u003e, to patient volume to ensure the Patient Acquisition Cost (PAC) remains healthy against Lifetime Value (LTV).\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUtilization vs. Marketing Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e2026 utilization targets are low: MD \u003cstrong\u003e55%\u003c\/strong\u003e, NP \u003cstrong\u003e50%\u003c\/strong\u003e, RN \u003cstrong\u003e45%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMarketing currently consumes \u003cstrong\u003e60%\u003c\/strong\u003e of total revenue.\u003c\/li\u003e\n\u003cli\u003eYou must lift patient volume without letting marketing costs grow faster than revenue.\u003c\/li\u003e\n\u003cli\u003eFixed overhead coverage depends entirely on filling these provider schedules.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMapping Acquisition Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCalculate the maximum allowable PAC based on average LTV.\u003c\/li\u003e\n\u003cli\u003eIf acquisition is too expensive, utilization gains won't translate to profit.\u003c\/li\u003e\n\u003cli\u003eFocus on protocols that drive high retention to increase LTV.\u003c\/li\u003e\n\u003cli\u003eIf PAC exceeds \u003cstrong\u003eone-third of LTV\u003c\/strong\u003e, you're overpaying for growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhere are we losing time or money due to clinical workflow inefficiencies?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eWorkflow inefficiencies in your Peptide Therapy Clinic are defintely costing you money by slowing patient throughput and forcing expensive Registered Nurses (RNs) to handle tasks lower-cost staff should manage. We need to map the patient journey right now to find where time bleeds out, especially around diagnostics and scheduling; you can see a deeper dive into related expenses here: \u003ca href=\"\/blogs\/operating-costs\/peptide-therapy\"\u003eWhat Are Peptide Therapy Clinic Operating Costs?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePinpointing Labor Leakage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStop RNs from doing administrative scheduling tasks immediately.\u003c\/li\u003e\n\u003cli\u003eCalculate the direct cost of task mismatch per hour.\u003c\/li\u003e\n\u003cli\u003eIf an RN spends 10 hours weekly coordinating, that's \u003cstrong\u003e$500\u003c\/strong\u003e lost value weekly.\u003c\/li\u003e\n\u003cli\u003eAudit EMR use; slow systems add minutes to every patient touchpoint.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixing Diagnostic Flow\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePhlebotomy utilization is only \u003cstrong\u003e60%\u003c\/strong\u003e; this is a major bottleneck.\u003c\/li\u003e\n\u003cli\u003eMap the exact time from patient check-in to blood draw completion.\u003c\/li\u003e\n\u003cli\u003eIf a Patient Coordinator can prep vials, free up the RN for clinical review.\u003c\/li\u003e\n\u003cli\u003eAnalyze if follow-up scheduling requires physician sign-off every time.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we willing to raise prices or bundle services to capture more value?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYes, you should defintely test a modest price increase on physician services immediately to gauge market tolerance while simultaneously pushing volume toward higher-margin NP services. Understanding the financial impact of these changes is crucial, which is why you need to review \u003ca href=\"\/blogs\/operating-costs\/peptide-therapy\"\u003eWhat Are Peptide Therapy Clinic Operating Costs?\u003c\/a\u003e before making final decisions.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTest MD Pricing Power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTest a \u003cstrong\u003e5%\u003c\/strong\u003e price increase on high-demand MD services.\u003c\/li\u003e\n\u003cli\u003eMD services currently start at \u003cstrong\u003e$850\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMeasure ARPP gain against patient churn risk.\u003c\/li\u003e\n\u003cli\u003eIf churn stays below \u003cstrong\u003e3%\u003c\/strong\u003e, the test is a win.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOptimize Service Mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShift practitioner capacity to Nurse Practitioner (NP) services.\u003c\/li\u003e\n\u003cli\u003eNP services should carry a higher contribution margin.\u003c\/li\u003e\n\u003cli\u003eBundle initial MD consults with subsequent NP visits.\u003c\/li\u003e\n\u003cli\u003eValue capture comes from efficient practitioner utilization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eAchieving target profitability hinges on immediately pushing clinical staff utilization rates above 70% to maximize revenue from existing fixed cost structures.\u003c\/li\u003e\n\n\u003cli\u003eThe most immediate profit boost comes from aggressively negotiating peptide sourcing and lab fees to reduce the Cost of Goods Sold (COGS) percentage.\u003c\/li\u003e\n\n\u003cli\u003eSustainable margin growth requires actively shifting the patient service mix toward higher-margin NP treatments and implementing modest annual price increases.\u003c\/li\u003e\n\n\u003cli\u003eWorkflow optimization and rigorously right-sizing labor ensure that high-cost providers are reserved exclusively for the highest-value patient interactions.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 1\n: \u003cspan style=\"color: #126CFF;\"\u003eMaximize Staff Utilization\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFocus on Utilization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou need to aggressively fill the \u003cstrong\u003e45% RN gap\u003c\/strong\u003e and \u003cstrong\u003e55% Health Coach gap\u003c\/strong\u003e projected for 2026. Since fixed overhead is already covered by existing volume, every new treatment booked through these underutilized roles drops almost entirely to the bottom line as pure contribution margin. This is where immediate profit lives.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost of Unused Time\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eUnfilled capacity is a hidden fixed cost. If RN salaries are $120,000 annually, a 45% gap means you are losing $54,000 in potential revenue generation per RN before accounting for variable costs. This calculation requires knowing total staff payroll against maximum potential treatment volume. What this estimate hides is the opportunity cost of delayed patient care.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eRN Annual Salary: $120,000\u003c\/li\u003e\n\u003cli\u003eTarget RN Treatment Price: $250\u003c\/li\u003e\n\u003cli\u003eLost Revenue Potential: 45% of total RN capacity value.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFilling the Capacity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo capture this margin, push patients toward RN services priced at \u003cstrong\u003e$250\u003c\/strong\u003e, rather than only high-end Medical Doctor consultations. Shift routine follow-ups away from $850 MDs to fill RN schedules first. Health Coaches need specific marketing pushes to fill their \u003cstrong\u003e55% void\u003c\/strong\u003e, perhaps bundling initial assessments. Defintely focus on scheduling efficiency.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePrioritize RN bookings ($250 ATV).\u003c\/li\u003e\n\u003cli\u003eDelegate routine tasks from MDs.\u003c\/li\u003e\n\u003cli\u003eCreate specific Health Coach intake packages.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eImmediate Profit Lever\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eOnce fixed overhead is covered-say, by existing MD revenue-every $250 RN treatment generates near-full contribution margin, assuming variable costs like peptides are manageable. This means aggressive scheduling incentives for RNs and Coaches now directly translate to immediate, high-quality profit growth, bypassing the need for major new overhead spending.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 2\n: \u003cspan style=\"color: #126CFF;\"\u003eImplement Tiered Pricing\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAnchor Price Increases\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou need systematic price increases coupled with value bundling to lift revenue per patient. Plan to raise average treatment prices by \u003cstrong\u003e3-5%\u003c\/strong\u003e yearly. Introduce premium packages that lock in high-value services like coaching and diagnostics right at the start.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCalculate Price Velocity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculate the required annual growth rate to hit the target price points. For MD services, moving from \u003cstrong\u003e$850 in 2026\u003c\/strong\u003e to \u003cstrong\u003e$950 by 2030\u003c\/strong\u003e requires a compound annual growth rate of about \u003cstrong\u003e2.8%\u003c\/strong\u003e. Premium tiers must bundle high-cost inputs like biomarker analysis and coaching to justify the higher price point immediately.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCurrent service prices\u003c\/li\u003e\n\u003cli\u003eTarget price escalator (3-5%)\u003c\/li\u003e\n\u003cli\u003eCost of bundled diagnostics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBundle for Higher ATV\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDon't just raise the base price; structure packages that force adoption of higher-value services. Premium tiers should automatically include initial coaching sessions and comprehensive diagnostics. This immediately lifts the Average Transaction Value (ATV) and covers upfront service costs before subsequent monthly treatments begin.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMandate diagnostics in top tier\u003c\/li\u003e\n\u003cli\u003ePrice coaching sessions into packages\u003c\/li\u003e\n\u003cli\u003eEnsure MDs only bill premium rates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eJustify Every Increase\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAffluent clients expect measurable ROI for every dollar spent on longevity treatments. If your \u003cstrong\u003e3-5%\u003c\/strong\u003e annual escalator isn't clearly tied to improved biomarker results or enhanced coaching access, patient churn risk increases defintely. Stick to the plan, but justify the increase every time.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 3\n: \u003cspan style=\"color: #126CFF;\"\u003eOptimize Service Mix\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eShift Service Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must steer volume from Registered Nurse (RN) services priced at \u003cstrong\u003e$250\u003c\/strong\u003e to Nurse Practitioner (NP) treatments priced at \u003cstrong\u003e$450\u003c\/strong\u003e. This direct service mix optimization immediately lifts your Average Transaction Value (ATV). If 50% of volume shifts from RN to NP, your blended ATV jumps from $350 to $400, assuming equal volume distribution across both tiers.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePricing Inputs Needed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eService mix is driven by practitioner time allocation and protocol complexity. To model this, you need the exact fee structure for every service tier: the \u003cstrong\u003e$450\u003c\/strong\u003e NP rate versus the \u003cstrong\u003e$250\u003c\/strong\u003e RN rate. This calculation determines your true revenue per hour of clinical capacity, which is crucial since revenue depends on practitioner output, not just patient count.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDriving High-Margin Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo execute this shift, train front-office staff to present the higher-value NP option first. Structure incentives for practitioners to recommend the \u003cstrong\u003e$450\u003c\/strong\u003e protocol over the \u003cstrong\u003e$250\u003c\/strong\u003e one. You want the patient journey to defintely favor the higher contribution service, maximizing revenue per available appointment slot.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWatch the Mix Ratio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTrack the percentage split between \u003cstrong\u003e$450\u003c\/strong\u003e NP services and \u003cstrong\u003e$250\u003c\/strong\u003e RN services weekly. If the ratio drifts toward RN services, overall margin erodes quickly, even if volume stays high. You need tight operational oversight here to maintain target profitability.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 4\n: \u003cspan style=\"color: #126CFF;\"\u003eNegotiate Peptide Sourcing\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTarget COGS Reduction\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must aggressively target cost of goods sold (COGS) components now, specifically sourcing and lab work. Aim to cut Compounded Peptide Sourcing, which is currently \u003cstrong\u003e85%\u003c\/strong\u003e of revenue, by \u003cstrong\u003e10-15%\u003c\/strong\u003e. Simultaneously, reduce Diagnostic Laboratory Fees, starting at \u003cstrong\u003e45%\u003c\/strong\u003e of revenue, by the same margin. This directly impacts gross margin quickly.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003ePeptide Sourcing covers the active ingredients needed for treatment protocols. Lab fees cover the biomarker analysis required for personalized dosing. To model savings, you need current vendor quotes and projected annual volume commitments. These two costs alone represent \u003cstrong\u003e130%\u003c\/strong\u003e of your current revenue base. What this estimate hides is that these are variable costs tied directly to service delivery.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePeptide cost: \u003cstrong\u003e85%\u003c\/strong\u003e revenue share.\u003c\/li\u003e\n\u003cli\u003eLab fees: \u003cstrong\u003e45%\u003c\/strong\u003e revenue share.\u003c\/li\u003e\n\u003cli\u003eTotal variable cost pressure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVendor Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReducing these high variable costs requires leverage. Stop using multiple small suppliers for peptides; consolidate purchasing power with one or two primary sources. Offer them guaranteed minimum annual spend for a steep discount. For labs, commit to a higher volume tier for testing to secure better per-test pricing. This is defintely doable.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eConsolidate peptide vendors now.\u003c\/li\u003e\n\u003cli\u003eCommit to higher annual volume.\u003c\/li\u003e\n\u003cli\u003eNegotiate better tier pricing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you achieve the low end of the target, a \u003cstrong\u003e10%\u003c\/strong\u003e reduction on the \u003cstrong\u003e85%\u003c\/strong\u003e sourcing cost frees up \u003cstrong\u003e8.5%\u003c\/strong\u003e of revenue. If you hit \u003cstrong\u003e15%\u003c\/strong\u003e on the \u003cstrong\u003e45%\u003c\/strong\u003e lab fees, that's another \u003cstrong\u003e6.75%\u003c\/strong\u003e. That combined \u003cstrong\u003e15.25%\u003c\/strong\u003e margin improvement flows straight to the bottom line, assuming fixed costs remain static.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 5\n: \u003cspan style=\"color: #126CFF;\"\u003eRight-Size Clinical Labor\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAlign Labor Value\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must immediately separate high-value Medical Doctor work from routine tasks. An MD consultation brings in \u003cstrong\u003e$850\u003c\/strong\u003e, but Registered Nurse time costs significantly less. Shifting simple follow-ups to RNs or Phlebotomists protects your highest-margin labor for complex cases. That's how you improve unit economics fast.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMD Cost Input\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eClinical labor cost is driven by the price per service slot, not just salary. The \u003cstrong\u003e$850\u003c\/strong\u003e MD treatment price is a direct input into your revenue calculation. You need hours billed versus revenue generated by role to see true utilization. What this estimate hides is the opportunity cost of using an MD for a $250 RN task.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMD Price: $850 per treatment\u003c\/li\u003e\n\u003cli\u003eRN Price: $250 per service\u003c\/li\u003e\n\u003cli\u003eFocus: High-value MD time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDelegation Tactics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eStop using your most expensive asset for low-leverage work. If an RN can handle the initial intake or blood draw (Phlebotomist work), the MD only steps in for complex protocol adjustments. This delegation protects the \u003cstrong\u003e$850\u003c\/strong\u003e revenue stream and maximizes output per physician hour. Don't defintely overpay for routine care.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShift intake tasks now\u003c\/li\u003e\n\u003cli\u003eProtect MD $850 slots\u003c\/li\u003e\n\u003cli\u003eUse RNs for $250 services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUtilization Lever\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEvery routine task delegated from an MD to an RN or Phlebotomist frees up capacity that generates \u003cstrong\u003e$600\u003c\/strong\u003e more margin per slot ($850 minus $250). This is a direct, measurable increase to contribution margin without raising prices or finding new patients.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 6\n: \u003cspan style=\"color: #126CFF;\"\u003eLower Customer Acquisition Cost (CAC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Acquisition Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou've got to aggressively shift acquisition spend away from digital channels. Moving Customer Acquisition Cost (CAC) from \u003cstrong\u003e60%\u003c\/strong\u003e of revenue down to \u003cstrong\u003e40%\u003c\/strong\u003e by Year 4 requires prioritizing patient retention and referral programs over costly new patient buys. This shift is crucial for margin expansion, defintely.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInitial Acquisition Drag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe initial \u003cstrong\u003e60%\u003c\/strong\u003e of revenue dedicated to acquisition reflects the high cost of reaching affluent clients seeking specialized peptide therapy. To calculate this, you need total monthly spend on digital ads, SEO, and lead generation against total monthly revenue. If initial revenue is $100k, $60k goes to CAC. This is unsustainable long-term.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMonthly digital ad spend.\u003c\/li\u003e\n\u003cli\u003eCost per qualified lead (CPQL).\u003c\/li\u003e\n\u003cli\u003eNew patient conversion rate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLowering Acquisition Drag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAchieving the \u003cstrong\u003e40%\u003c\/strong\u003e CAC target means investing in programs that drive organic growth. Referrals and keeping existing patients are cheaper than constantly buying new ones. If a new patient costs $1,500 to acquire digitally, a referral might cost $150 in incentives. You must track patient lifetime value (LTV) versus CAC closely.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLaunch a tiered patient referral bonus.\u003c\/li\u003e\n\u003cli\u003eIncrease patient engagement touchpoints.\u003c\/li\u003e\n\u003cli\u003eFocus on high-value patient retention rates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRetention Profit Lift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEvery percentage point you shave off CAC directly flows to contribution margin, especially since fixed costs are covered by existing utilization. If you save \u003cstrong\u003e20%\u003c\/strong\u003e of revenue ($20k on $100k revenue) by Year 4, that $20k is pure profit lift, assuming variable costs remain stable. This is a massive lever for profitability.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 7\n: \u003cspan style=\"color: #126CFF;\"\u003eReview Overhead Leases\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Fixed Lease Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour fixed overhead, excluding wages, sits at \u003cstrong\u003e$20,000\u003c\/strong\u003e monthly, which pressures profitability immediately. The \u003cstrong\u003ePremium Clinic Lease\u003c\/strong\u003e at \u003cstrong\u003e$12,500\u003c\/strong\u003e is the single biggest lever here. You must aggressively negotiate this cost when the lease comes up for renewal to improve your runway.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePinpoint Overhead Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$20,000\u003c\/strong\u003e monthly fixed spend covers essential non-wage overhead. The primary input is the \u003cstrong\u003e$12,500\u003c\/strong\u003e lease payment for your physical clinic space. Insurance costs are also bundled here. If you hit break-even at \u003cstrong\u003e$20k\u003c\/strong\u003e fixed, every dollar saved directly boosts net income, so this cost needs immediate attention.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eNegotiate Lease Timing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFocus negotiation efforts on the lease renewal date, which is your best leverage point. Look at comparable market rates for similar square footage in your metro area. If you achieve even a \u003cstrong\u003e10%\u003c\/strong\u003e reduction on the lease, that's \u003cstrong\u003e$1,250\u003c\/strong\u003e saved monthly, or \u003cstrong\u003e$15,000\u003c\/strong\u003e annually. Don't forget to shop insurance quotes too.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAction on Lease Expiration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTrack the exact date your \u003cstrong\u003ePremium Clinic Lease\u003c\/strong\u003e expires; this dictates when you can push for better terms. If market rents have flattened or dropped, aim to cut that \u003cstrong\u003e$12,500\u003c\/strong\u003e line item by at least \u003cstrong\u003e5%\u003c\/strong\u003e. Defintely review all insurance policies against competitors' coverage levels before renewing.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304118165747,"sku":"peptide-therapy-profitability","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/peptide-therapy-profitability.webp?v=1782689057","url":"https:\/\/financialmodelslab.com\/products\/peptide-therapy-profitability","provider":"Financial Models Lab","version":"1.0","type":"link"}